PPA
WVE icon

Parametric Portfolio Associates’s Wave Life Sciences WVE Stock Holding History

Parametric Portfolio Associates’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$113K Buy
56,544
+22,018
+64% +$53.9K ﹤0.01% 3547
2021
Q4 		$108K Buy
34,526
+24,019
+229% +$99.7K ﹤0.01% 3540
2021
Q3 		$51K Sell
10,507
-4,950
-32% -$30K ﹤0.01% 3573
2021
Q2 		$103K Buy
+15,457
New +$101K ﹤0.01% 3479
2020
Q4 		– Sell
-42,167
Closed -$358K – 4033
2020
Q3 		$358K Sell
42,167
-264
-0.6% -$2.89K ﹤0.01% 3415
2020
Q2 		$442K Buy
42,431
+31,601
+292% +$297K ﹤0.01% 3334
2020
Q1 		$101K Sell
10,830
-30,008
-73% -$256K ﹤0.01% 3732
2019
Q4 		$327K Buy
40,838
+9,800
+32% +$240K ﹤0.01% 3535
2019
Q3 		$637K Buy
31,038
+9,851
+46% +$226K ﹤0.01% 3249
2019
Q2 		$553K Sell
21,187
-3,549
-14% -$99.5K ﹤0.01% 3322
2019
Q1 		$961K Sell
24,736
-3,329
-12% -$135K ﹤0.01% 3050
2018
Q4 		$1.18M Buy
28,065
+788
+3% +$35K ﹤0.01% 2884
2018
Q3 		$1.36M Buy
27,277
+2,532
+10% +$114K ﹤0.01% 2932
2018
Q2 		$946K Sell
24,745
-23,811
-49% -$1.03M ﹤0.01% 3088
2018
Q1 		$1.95M Buy
48,556
+28,581
+143% +$1.2M ﹤0.01% 2646
2017
Q4 		$701K Sell
19,975
-3,641
-15% -$106K ﹤0.01% 3175
2017
Q3 		$514K Buy
23,616
+6,885
+41% +$138K ﹤0.01% 3407
2017
Q2 		$311K Buy
+16,731
New +$361K ﹤0.01% 3619

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Parametric Portfolio Associates's WVE Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Wave Life Sciences (WVE) stake by 64% in Q1 2022, buying an estimated $53.9K and bringing the position to 56,544 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #3547.

Parametric Portfolio Associates first reported a position in WVE in Q2 2017 and has held it in 18 quarters since. The position peaked at $1.95M in Q1 2018. 82 funds tracked by Wall St. Rank hold WVE as of Q1 2022.

  • Parametric Portfolio Associates held 56,544 shares of Wave Life Sciences worth $113K as of Q1 2022.
  • Parametric Portfolio Associates bought 22,018 Wave Life Sciences shares in Q1 2022, an estimated $53.9K.
  • Wave Life Sciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3547 holding.
  • Parametric Portfolio Associates first reported a position in Wave Life Sciences in Q2 2017 and has held it in 18 quarters since.
  • Parametric Portfolio Associates's Wave Life Sciences position peaked at $1.95M in Q1 2018.
  • 82 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.